{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:02:35Z","timestamp":1789970555867,"version":"4.0.1"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Circulating apolipoprotein A1 (ApoA1) and apolipoprotein B (ApoB) have been proposed as vital biomarkers in the pathological process of coronary heart disease (CAD). However, their associations with novel cardiometabolic indices [triglyceride glucose body mass index (TyG-BMI), atherogenic index of plasma (AIP), and atherogenic index (AI)] remain scarce in CAD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 11,934 patients with CAD (average age: 61.7 years) were included in this hospital-based cross-sectional study. TyG-BMI, AIP, and AI were calculated using the following formulas: TyG index = Ln[FBG (mg\/dL) \u00d7 triglyceride (mg\/dL)\/2], Log[triglyceride (mg\/dL)\/high-density lipoprotein cholesterol (HDL-C, mg\/dL)], and non-HDL-C (mg\/dL)\/HDL-C (mg\/dL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, serum ApoA1 was inversely associated with TyG-BMI, AIP, and AI, while ApoB and the ApoB\/A1 ratio exhibited positive associations with TyG-BMI, AIP, and AI. In multivariable analysis, ApoA1 was inversely associated with cardiometabolic indices [TyG-BMI\n                      <jats:sub>Q(quartile)4 vs. Q1<\/jats:sub>\n                      : 225.800 vs. 228.217, AIP\n                      <jats:sub>Q4 vs. Q1<\/jats:sub>\n                      : 0.356 vs. 0.478, AI\n                      <jats:sub>Q4 vs. Q1<\/jats:sub>\n                      : 1.928 vs. 2.525]. In contrast, ApoB and the ApoB\/A1 ratio were positively associated with cardiometabolic indices. The corresponding values for TyG-BMI, AIP, and AI were 236.772 (vs. 217.018) and 236.724 (vs. 216.873), 0.478 (vs. 0.304) and 0.512 (vs. 0.285), and 3.097 (vs. 1.652) and 3.159 (vs. 1.544) in Q4 group of ApoB and ApoB\/A1 ratio compared with Q1 group. Similar results were observed in the subgroup analysis stratified by sex.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ApoA1 was inversely associated with novel cardiometabolic indices (TyG-BMI, AIP, and AI) in CAD patients, while ApoB and the ApoB\/A1 ratio demonstrated significant positive associations with these cardiometabolic indices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1893486","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:34:51Z","timestamp":1789968891000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of apolipoprotein A1, apolipoprotein B, and their ratio with novel cardiometabolic indices in adults with coronary artery disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Ping","family":"Hu","sequence":"first","affiliation":[{"name":"Image Center, Wuhan Asia Heart Hospital","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Psycho-Cardiology, Beijing Anzhen Hospital Affiliated to Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Image Center, Wuhan Asia Heart Hospital","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Dong","sequence":"additional","affiliation":[{"name":"Scientific Education Section and Department of Child Healthcare, Affiliated Maternity & Child Health Care Hospital of Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3969\/j.issn.1000-3614.2024.07.001","article-title":"Report on cardiovascular health and diseases in China 2023: an updated summary","volume":"39","year":"2024","journal-title":"Chin Circ J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.14744\/AnatolJCardiol.2024.4407","article-title":"Evaluating the prognostic nutritional index for predicting the clinical relevance of angiographically intermediate coronary lesions","volume":"29","author":"\u00d6zkan","year":"2025","journal-title":"Anatol J Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.14744\/AnatolJCardiol.2024.4632","article-title":"The interplay of atherothrombotic factors and the evolving landscape of atherosclerotic cardiovascular disease: comprehensive insights from recent studies","volume":"28","author":"Alrahimi","year":"2024","journal-title":"Anatol J Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1573403x15666190522100041","article-title":"Pragmatic analysis of dyslipidemia involvement in coronary artery disease: a narrative review","volume":"16","author":"Mih\u0103il\u0103","year":"2020","journal-title":"Curr Cardiol Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.14744\/AnatolJCardiol.2024.4001.","article-title":"The role of pyroptosis in coronary heart disease","volume":"28","author":"Qiu","year":"2024","journal-title":"Anatol J Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/mca.0000000000001380","article-title":"Association of apolipoprotein B and apolipoprotein A1 levels with social determinants of health and coronary artery disease mortality in the United Kingdom Biobank\u2014is there a need for consideration?","volume":"35","author":"F\u00fcller","year":"2024","journal-title":"Coron Artery Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e2352572","DOI":"10.1001\/jamanetworkopen.2023.52572","article-title":"Dose-response associations of lipid traits with coronary artery disease and mortality","volume":"7","author":"Yang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/ijms21030732","article-title":"Advances in HDL: much more than lipid transporters","volume":"21","author":"Ben-Aicha","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4610834","article-title":"Apolipoprotein A1-related proteins and reverse cholesterol transport in antiatherosclerosis therapy: recent progress and future perspectives","volume":"2022","author":"Xu","year":"2022","journal-title":"Cardiovasc Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/metabo11100690","article-title":"Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target","volume":"11","author":"Behbodikhah","year":"2021","journal-title":"Metabolites"},{"key":"B13","doi-asserted-by":"publisher","first-page":"117389","DOI":"10.1016\/j.atherosclerosis.2023.117389","article-title":"Atherogenic index predicts all-cause and cardiovascular mortality in incident peritoneal dialysis patients","volume":"387","author":"Deng","year":"2023","journal-title":"Atherosclerosis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12933-024-02198-y","article-title":"The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: a systematic review and meta-analysis","volume":"23","author":"Rabiee Rad","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1140215","DOI":"10.3389\/fcvm.2023.1140215","article-title":"The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease","volume":"10","author":"Li","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-022-01606-5","article-title":"Association between the triglyceride-glucose index and severity of coronary artery disease","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","article-title":"Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals","volume":"11","author":"Er","year":"2016","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-025-02584-0","article-title":"Triglyceride-glucose-body mass index and the incidence of cardiovascular diseases: a meta-analysis of cohort studies","volume":"24","author":"Rao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0009-9120(01)00263-6","article-title":"The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FERHDL)","volume":"34","author":"Dobi\u00e1sov\u00e1","year":"2001","journal-title":"Clin Biochem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jpeds.2012.06.013","article-title":"Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth","volume":"161","author":"Burns","year":"2012","journal-title":"J Pediatr"},{"key":"B21","first-page":"248","article-title":"Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria","volume":"10","author":"Nwagha","year":"2010","journal-title":"Afr Health Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12882-020-01993-5","article-title":"Elevated TG\/HDL-C and non-HDL-C\/HDL-C ratios predict mortality in peritoneal dialysis patients","volume":"21","author":"Xia","year":"2020","journal-title":"BMC Nephrol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1515\/bjmg-2017-0002","article-title":"Association of the apolipoprotein A-I gene polymorphisms with cardiovascular disease risk factors and atherogenic indices in patients from Assam, northeast India","volume":"20","author":"Bora","year":"2017","journal-title":"Balkan J Med Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/591454","article-title":"The apolipoprotein B\/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity","volume":"2015","author":"Kaneva","year":"2015","journal-title":"Dis Markers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12944-018-0759-8","article-title":"Association of the APOA1 rs964184 SNP and serum lipid traits in the Chinese Maonan and Han populations","volume":"17","author":"Qiu","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e016839","DOI":"10.1161\/jaha.120.016839","article-title":"Effects of evolocumab on low-density lipoprotein cholesterol, non\u2013high density lipoprotein cholesterol, apolipoprotein B, and lipoprotein(a) by race and ethnicity: a meta-analysis of individual participant data from double-blind and open-label extension studies","volume":"10","author":"Daviglus","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1161\/01.atv.13.7.1037","article-title":"Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study","volume":"13","author":"Marcovina","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/jch.14751","article-title":"Novel lipid biomarkers and ratios as risk predictors for premature coronary artery disease: a retrospective analysis of 2952 patients","volume":"25","author":"Chen","year":"2023","journal-title":"J Clin Hypertens"},{"key":"B29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2019.21782","article-title":"Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease","volume":"323","author":"Mosley","year":"2020","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4678526","article-title":"Diagnostic accuracy of the triglyceride and glucose Index for insulin resistance: a systematic review","volume":"2020","author":"S\u00e1nchez-Garc\u00eda","year":"2020","journal-title":"Int J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12902-023-01372-9","article-title":"The association between cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study","volume":"23","author":"Zakerkish","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/ijpo.12147","article-title":"APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children","volume":"12","author":"Su\u00e1rez-S\u00e1nchez","year":"2017","journal-title":"Pediatr Obes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12944-017-0446-134","article-title":"Low apoA-I is associated with insulin resistance inpatients with impaired glucose tolerance: a cross-sectional study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12902-021-00726-5","article-title":"Association of apolipoproteins A1 and B withtype 2 diabetes and fasting blood glucose: a cross-sectional study","volume":"21","author":"Gao","year":"2021","journal-title":"BMC EndocrDisord"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1161\/atvbaha.123.318267","article-title":"ApoA-I and diabetes","volume":"43","author":"King","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00125-014-3162-7","article-title":"Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice","volume":"57","author":"Stenkula","year":"2014","journal-title":"Diabetologia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.ejhg.5201362","article-title":"Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD","volume":"13","author":"Souverein","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/ijms26031051","article-title":"Overexpression of apolipoprotein A-I alleviates insulin resistance in MASLD mice through the PPAR\u03b1 pathway","volume":"26","author":"Wang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1476-511x-11-131","article-title":"Regulation of adipocyte autophagy\u2014the potential anti-obesity mechanism of high density lipoprotein and ApolipoproteinA-I","volume":"11","author":"Wang","year":"2012","journal-title":"Lipids Health Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2174\/1566524022666220607085908","article-title":"Apolipoprotein A1 inhibits adipogenesis progression of human adipose-derived mesenchymal stem cells","volume":"23","author":"Su","year":"2023","journal-title":"Curr Mol Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.cellsig.2015.05.003","article-title":"Apolipoprotein a1 increases mitochondrial biogenesis through AMP-activated protein kinase","volume":"27","author":"Song","year":"2015","journal-title":"Cell Signal"},{"key":"B42","doi-asserted-by":"publisher","first-page":"100949","DOI":"10.1016\/j.molmet.2020.01.013","article-title":"ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPK\u03b12","volume":"35","author":"Fritzen","year":"2020","journal-title":"Mol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.bbadis.2018.05.014","article-title":"Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism","volume":"1864","author":"Domingo-Espin","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/atvbaha.118.312282","article-title":"Apolipoprotein A-I protects against pregnancy-induced insulin resistance in rats","volume":"39","author":"Wu","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.jacc.2024.03.423","article-title":"Excess apolipoprotein B and cardiovascular risk in women and men","volume":"83","author":"Johannesen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"106873","DOI":"10.1016\/j.phrs.2023.106873","article-title":"Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment","volume":"195","author":"Galimberti","year":"2023","journal-title":"Pharmacol Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijcard.2006.03.005","article-title":"Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia","volume":"115","author":"Pei","year":"2007","journal-title":"Int J Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/BF02591655","article-title":"A study of correlation between apolipoprotein B and dyslipidemia in type 2 diabetes patients and its relation with proteinuria\u2014a tertiary care hospital based study","volume":"67","author":"Kumar","year":"2019","journal-title":"J Assoc Physicians India"},{"key":"B49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/bf02591655","article-title":"Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females","volume":"21","author":"Jungner","year":"1992","journal-title":"Int. J Clin Lab Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4149\/bll_2023_094","article-title":"Association of lipid parameters with insulin resistance in the Kazakh population","volume":"124","author":"Shakhanova","year":"2023","journal-title":"Bratisl Lek Listy"},{"key":"B51","doi-asserted-by":"publisher","first-page":"147703","DOI":"10.1016\/j.gene.2023.147703","article-title":"Apo B-48 gene expression and low-density lipoprotein as a factor for increased insulin resistance and severity of acne","volume":"885","author":"AbdElneam","year":"2023","journal-title":"Gene"},{"key":"B52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2004.11.009","article-title":"Association between insulin resistance and apolipoprotein B in normoglycemic Koreans","volume":"180","author":"Sung","year":"2005","journal-title":"Atherosclerosis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.3390\/ijms24076310","article-title":"The correlation of apolipoprotein B with alterations in specific fat depots content in adults","volume":"24","author":"Chen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1194\/jlr.M066613","article-title":"The effects of apolipoprotein B depletion on HDL subspecies composition and function","volume":"57","author":"Davidson","year":"2016","journal-title":"J Lipid Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pharmthera.2009.04.005","article-title":"Therapeutic regulation of ApoB100 metabolism in insulin resistance in vivo","volume":"123","author":"Watts","year":"2009","journal-title":"Pharmacol Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.22960","article-title":"Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance","volume":"50","author":"Su","year":"2009","journal-title":"Hepatology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e85656","DOI":"10.7759\/cureus.85656","article-title":"Apolipoprotein B and glycemic indices in normoglycemic adults: analysis of the national health and nutrition examination survey, 2007\u20132016","volume":"17","author":"Agoons","year":"2025","journal-title":"Cureus"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e3771","DOI":"10.1371\/journal.pone.0003771","article-title":"ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes","volume":"3","author":"Skogsberg","year":"2008","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cca.2020.01.015","article-title":"The exchangeable apolipoproteins in lipid metabolism and obesity","volume":"503","author":"Xin","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B60","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2796.2006.01644.x","article-title":"Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B\/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies","volume":"259","author":"Thompson","year":"2006","journal-title":"J Intern Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-019-1144-y","article-title":"Comparison of apolipoprotein B\/A1 ratio, Framingham risk score and TC\/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention","volume":"18","author":"Tian","year":"2019","journal-title":"Lipids Health Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40200-023-01235-z","article-title":"The association of the apolipoprotein B\/A1 ratio and the metabolic syndrome in children and adolescents: a systematic review and meta-analysis","volume":"23","author":"Dinpanah","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"B63","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1210\/en.2013-1112","article-title":"How estrogens prevent from lipid-induced insulin resistance","volume":"154","author":"Jelenik","year":"2013","journal-title":"Endocrinology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.7150\/ijbs.86475","article-title":"Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis","volume":"19","author":"Li","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12944-023-01860-w","article-title":"Association of apolipoproteins and lipoprotein(a) with metabolic syndrome: a systematic review and meta-analysis","volume":"22","author":"Ulloque-Badaracco","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/biom12101439","article-title":"Integrated quantitative targeted lipidomics and proteomics reveal unique fingerprints of multiple metabolic conditions","volume":"12","author":"Ivanova","year":"2022","journal-title":"Biomolecules"},{"key":"B67","doi-asserted-by":"publisher","first-page":"d464","DOI":"10.2741\/1022","article-title":"Mechanisms of metabolic dyslipidemia in insulin resistant states deregulation of hepatic and intestinal lipoprotein secretion","volume":"8","author":"Avramoglu","year":"2003","journal-title":"Front Biosci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"427","DOI":"10.26502\/fccm.92920466","article-title":"Apolipoprotein B in the risk assessment, diagnosis, and treatment of cardiometabolic diseases","volume":"9","author":"Patel","year":"2025","journal-title":"Cardiol Cardiovasc Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1893486\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:34:54Z","timestamp":1789968894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1893486\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":68,"alternative-id":["10.3389\/fcvm.2026.1893486"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1893486","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1893486"}}